Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs.
about
Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysisA systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region.Patients receiving opioid maintenance treatment in primary care: successful chronic hepatitis C care in a real world setting.Psychiatric care of the patient with hepatitis C: a review of the literature.Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care.Efficacy of peginterferon plus ribavirin in patients receiving opioid substitution therapy : Final results of the Austrian PegHope study.
P2860
Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Swiss multicenter study evalua ...... opiate substitution programs.
@en
Swiss multicenter study evalua ...... opiate substitution programs.
@nl
type
label
Swiss multicenter study evalua ...... opiate substitution programs.
@en
Swiss multicenter study evalua ...... opiate substitution programs.
@nl
prefLabel
Swiss multicenter study evalua ...... opiate substitution programs.
@en
Swiss multicenter study evalua ...... opiate substitution programs.
@nl
P2093
P356
P1433
P1476
Swiss multicenter study evalua ...... opiate substitution programs.
@en
P2093
André Seidenberg
Barbara Broers
Christoph Kölliker
Marc Isler
Markus Frei
Markus Herold
Martine Monnat
Milo Huber
Patrick Schmid
Peter Schönbucher
P304
P356
10.1159/000173733
P577
2008-11-21T00:00:00Z